Feed Skupnost
BC
Bill Combs
@billcombs · 20. jul.

Investors, the pharmaceutical company Johnson & Johnson reported results today and the results beat expectations. Overall, I see potential in pharmaceutical and medical device companies and I like to invest in them. I already have $CVS in my portfolio and plan to add $PFE to my portfolio. I would like to add $JNJ to my portfolio, but it is at a high price and I fear it will be at a high price for a long time.

Revenues : $25.53 billion and expected $24.63 billion.

EPS : $2.8 and $2.6 was expected.

Do you have $JNJ stock included in your portfolio or would you like to include it in your portfolio?

Osebni pogled člana skupnosti, ne naložbeno priporočilo. Pravila skupnosti

RR
Rickie Reeve @rickiereeve 20. jul.

$JNJ is probably a fine company too, such a classic. I already have $PFE and $CVS, so I'm not thinking about it though, I'd rather build those positions.

BC
Bill Combs @billcombs 21. jul.

Great, I have a similar approach and opinion, but if JNJ shares were to drop significantly I would definitely buy.

MD
Monday Dayton @mondaydayton 20. jul.

Today this sexton pleased very much. I have mentioned $CVS and it makes me happy. Well then I kind of regret the $JNJ, I've been thinking about it too but since I also have maybe $MPW which is such a reit healthcare and then the failure with $NVAX so I'm thinking, I won't cram more in the healthcare for now, no mistake, $JNJ jumped very nicely today and I agree with the views that it won't go down much on discounts so it was probably a mistake not to buy. To those holding on, congrats. 👍

BC
Bill Combs @billcombs 21. jul.

Great, I agree. I'm not familiar with $MPW, but it looks interesting and I'll definitely check out this company.

WS
Willard Spencer @willardspencer 20. jul.

I also wanted to "diversify" a bit away from technology and tourism, so I bought CVS at $70 but I'm not really interested in anything else in that sector and I don't see much potential there either. Resp. gradual growth I guess, I'm just looking for "wilder" stocks :)

BC
Bill Combs @billcombs 20. jul.

Sure I get it, these stocks are probably not going to grow by tens or hundreds of % a year :D. CVS I was also overbought around that $70 mark.

MP
Mart Poom @martpoom 20. jul.

There's nothing to solve here. $JNJ is the top, one just must not expect any ultra potential

BC
Bill Combs @billcombs 20. jul.

I fully agree :)

BG
Barrett Gardener @justbarrett 20. jul.

I also like $JNJ and I'd say that price won't really see any big discounts.

MP
Mart Poom @martpoom 20. jul.

There's some litigation going on right now that could drive the price up, but probably not drastically

DD
Daniela Duong @danieladuong 20. jul.

Jnj won't go down much in my opinion.

MP
Mart Poom @martpoom 20. jul.

He will. There will always be movement, but it probably won't be a slump like the little California growth spurt.

JB
Jason Bellier @neostonks 20. jul.

I was thinking about JNJ at $154, but ultimately hesitated. I guess you can't get it much cheaper than that. If you look at the chart, -7% YTD is still interesting.

MP
Mart Poom @martpoom 20. jul.

For a company this stable, -7% for the year is actually pretty interesting 🤔😂

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.